The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Infectious diseases (ID) have always been a significant threat in the management of solid organ transplant (SOT) recipients, often counterbalancing our efforts to control alloimmune response to prevent organ rejection. However, in recent years, the COVID-19 pandemic, the outbreak of new multi-drug resistant pathogens, and the availability of new antimicrobial agents enhanced the need for close interaction between the community of transplant physicians, surgeons, and infectious disease specialists. In the context of ESOT’s efforts to foster greater multidisciplinarity, we identified the need to convene a group of experts to work towards a strategy for assessing unmet needs and gaps related to ID in SOT. Therefore, the ESOT Council deliberated to establish a transversal task force of transplant professionals and infectious disease specialists to deliver activities in transplant infections.
The scope of this task force will be to assist ESOT and its Sections and Committees in planning and conducting activities focused on preventing and treating infectious complications in organ transplant recipients. The portfolio of this task force will include, but will not be limited to, ongoing projects in the transplant ID setting. These comprise the update of, and the dissemination activities related to, the COVID-19 position statement, the educational and scientific projects related to new CMV treatments coming to the market, the identification of needs for specific guidelines or position documents about clinical controversies in transplant ID management, and the related collaboration with industry in this setting.
Assist ESOT and its sections and committees in planning and conducting activities focused on the prevention and treatment of infectious complications in organ transplant recipients.
Current activities in the ID field and portfolio of the task force :
Jose Maria Aguado (Spain), Gregor Bond (Austria), Saskia Bos (Belgium), David Cucchiari (Spain), Paolo Grossi (Italy), Nassim Kamar (France), Hannah Kaminski (France), Oriol Manuel (Switzerland), Berta Saez-Gimenez (Spain), Ines Ushiro-Lumb (United Kingdom), Sophie Alain (France).
and with Liaisons
Anna Forsberg (Sweden), Luciano Potena (Italy), Luca Toti (Italy)
